Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter S. Liaw"'
Autor:
William P. Sheffield, Sharon Gataiance, Gonzalo Hortelano, Frederick A. Ofosu, Megan E. Begbie, Peter S. Liaw, Louise Eltringham-Smith, Rina A. Leyva, Asif Mamdani
Publikováno v:
British Journal of Haematology. 126:565-573
Summary Individuals with haemophilia B require replacement therapy with recombinant or plasma-derived coagulation factor IX (fIX). More benefit per injected dose might be obtained if fIX clearance could be slowed. The contribution of overall size to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c26fdd3e2bc7b70d8b35a7ae57afaec7
https://doi.org/10.1111/j.1365-2141.2004.05106.x
https://doi.org/10.1111/j.1365-2141.2004.05106.x
Publikováno v:
Biochemistry. 43(46)
The abundant plasma protein alpha(1)-proteinase inhibitor (alpha(1)-PI) physiologically inhibits neutrophil elastase (NE) and factor XIa and belongs to the serine protease inhibitor (serpin) protein superfamily. Inhibitory serpins possess a surface p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f0ddfad781f8f78e3ccc33b94e15b1
https://pubmed.ncbi.nlm.nih.gov/15544357
https://pubmed.ncbi.nlm.nih.gov/15544357
Autor:
William P, Sheffield, Asif, Mamdani, Gonzalo, Hortelano, Sharon, Gataiance, Louise, Eltringham-Smith, Megan E, Begbie, Rina A, Leyva, Peter S, Liaw, Frederick A, Ofosu
Publikováno v:
British journal of haematology. 126(4)
Individuals with haemophilia B require replacement therapy with recombinant or plasma-derived coagulation factor IX (fIX). More benefit per injected dose might be obtained if fIX clearance could be slowed. The contribution of overall size to fIX clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06f442c30c718361991bcdd11358d000
https://pubmed.ncbi.nlm.nih.gov/15287951
https://pubmed.ncbi.nlm.nih.gov/15287951